A larger Novo Nordisk-funded trial found that patients in earlier stages taking semaglutide were more likely than those on a placebo to see their NASH resolved, but not significantly more likely to see their scarring improve
Both compounds have demonstrated significant biological activity in experimental models and have begun to attract attention from healthcare professionals seeking novel therapeutic modalities
This data should be interpreted with a qualified healthcare provider to inform which GLP-1 type or protocol might align with your biological profile
Currently, there are no absolute contraindications to semaglutide use based solely on the presence of an autoimmune condition
One of the most promising developments in obesity medicine is Orforglipron , an oral GLP-1 receptor agonist
Meanwhile, it is essential to note that administering vitamin D without proper scientific guidance may lead to elevated serum concentrations of 25-hydroxyvitamin D and free 1,25-dihydroxy vitamin D, as well as an array of chronic toxic effects, such as hypercalcemia and hypercalciuria, that can result in renal calcium deposition
